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Abstract
The transcription factor SOX3 is expressed within most neural progenitor (NP) cells of the vertebrate central nervous system
(CNS) and is essential for normal brain development in mice and humans. However, despite the widespread expression of
Sox3, CNS defects in null mice are relatively mild due to functional redundancy with the other SOXB1 sub-group members
Sox1 and Sox2. To further understand the molecular function of SOX3, we investigated the genome-wide binding profile of
endogenous SOX3 in NP cells using ChIP-seq. SOX3 binding was identified at over 8,000 sites, most of which were intronic
or intergeneic and were significantly associated with neurodevelopmental genes. The majority of binding sites were
moderately or highly conserved (phastCons scores .0.1 and 0.5, respectively) and included the previously characterised,
SOXB1-binding Nestin NP cell enhancer. Comparison of SOX3 and published ChIP-Seq data for the co-activator P300 in
embryonic brain identified hundreds of highly conserved putative enhancer elements. In addition, we identified a subset of
highly conserved putative enhancers for CNS development genes common to SOXB1 members in NP cells, all of which
contained the SOX consensus motif (ACAAWR). Together these data implicate SOX3 in the direct regulation of hundreds of
NP genes and provide molecular insight into the overlapping roles of SOXB1 proteins in CNS development.
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Introduction
The SOX (Sry-related HMG box) family of transcription factors
(TFs) are expressed in most if not all developing tissues and have
critical roles in stem/progenitor cell induction, maintenance and
differentiation [1,2] SOX proteins bind to the minor groove of
DNA via an HMG box that has at least 50% identity to the
founding member SRY and recognise variations of the core
consensus sequence AACAAW (W=A or T) [2–4]. In vivo, SOX
factor binding typically occurs in association with partner proteins,
many of which belong to other major TF families including POU-
Oct and zinc finger proteins [5].
Twenty SOX genes have been identified in mammals, which
have been divided into groups based on their overall sequence
homology. Sox3, Sox2 and Sox1 belong to the SOXB1 subgroup.
These genes are expressed in neural progenitor (NP) cells
throughout the vertebrate neuroaxis and are generally downreg-
ulated during NP differentiation [6]. In vitro and in vivo data
indicate that SOX3 acts predominantly as a transcriptional
activator, although there is also evidence supporting repressive
activity [1,7,8]. Enforced expression of SOX3 in neural progen-
itors (NP) actively represses their differentiation functioning at least
in part to repress Notch signalling [9]. Recent data also suggests
that SOX3 may function as a pioneer factor through binding to
neuronal-specific genes, priming them for subsequent activation by
SOX11 [1,2]. Despite the widespread expression of Sox3 in the
developing CNS, Sox3 null mice exhibit relatively mild neurode-
velopmental defects, which are restricted to the hypothalamic-
pituitary axis, the corpus callosum and the hippocampus [10,11].
CNS deletion of the other SoxB1 genes is also relatively mild
[12,13]. Together, these data, coupled with overexpression
analysis, indicate that SOXB1 proteins functionally interchange-
able. This is supported by the recent observation that SOX3 binds
to 96% of the known SOX2 binding sites within NP cells [2].
The development of ChIP-seq technology in recent years has
provided invaluable insight into TF biology [14–16]. These data
have highlighted the complexity of transcription factor activity by
demonstrating TFs can have tens of thousands of binding sites
within a single cell population. While it has been known for many
years that TFs can act over long distances, a recent RNAPII ChIP-
PET study has added to this complexity by providing further
evidence for transcription factor mediated interchromsomal
interactions [17]. Many TF binding sites are found at enhancers,
promoting gene expression through the recruitment of TFs,
cofactors (such as CBP/P300) and RNA Polymerase II (RNAPII)
while looping DNA to the target promoter [18]. The ENCODE
project has identified ,400,000 putative enhancer regions in
human cell lines based on genomic traits including chromatin
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methylation and acetylation status, evolutionary conservation and
TF binding motifs [19]. Given the human and mouse genomes are
in the same order of magnitude, it seems likely that there are a
similar number of enhancers. By combining existing data for
enhancer regions with TF binding site locations identified using
ChIP-seq, we can identify putative enhancers for transcription
factors such as SOX3, and begin to understand the functional
significance of the vast expanses of non-coding genomic regions.
Identifying SOX3 binding sites and enhancers is crucial for
complete understanding of the role of SOXB1 proteins in neural
development. Here we present a genome-wide analysis of SOX3
binding in NP cells using ChIP-Seq. Through integration of this
data with additional existing datasets we provide evidence that
SOX3 and its SOXB1 partners activate hundreds of neurodevel-
opmental genes through binding to evolutionarily conserved
sequences located principally within intergeneic regions. We also
identify a putative multi-gene transcriptional hub, implicating
SOX3 in interchromosal transcriptional regulation.
Results
Identification of SOX3 binding sites in Neural Progenitor
cells
To identify genomic binding sites of endogenous SOX3 protein,
we performed ChIP-Seq analysis of NP cells generated from
embryonic stem cells by N2B27 neuroinduction [20]. We have
shown previously that these NP cells exhibit robust SOX3
expression [21] and that the SOX3 antibody used for ChIP has
specific activity in immunohistochemistry [6] and Western blot
analyses [22]. A total of 8067 common binding sites were
identified across three independent samples (Figure 1A; Table
S1). ChIP-Seq data was validated using ChIP-qPCR on indepen-
dently generated samples, with all but one of the SOX3 binding
sites (SBS) tested showing enrichment (Figure 1B). A de novo
analysis of the full set of ChIP peaks was performed to identify
enriched DNA motifs. Comparison with the JASPAR database
[23] confirmed that the most common motif was a SOX binding
motif (Figure 1C) (with at least one occurrence within .70% of
peaks, p-value less than 1026, and an expected background
occurrence of 39%), which was similar to the motif identified in a
recently published SOX3 ChIP dataset [2]. The second most
common motif features paired SOX/POU binding sites separated
by a single nucleotide (Figure 1C) (with at least one occurrence
within .40% of peaks). Motifs for other neural TF classes, such as
the Zic, Klf and Engrailed families, were also enriched within
1215, 979 and 647 peaks respectively (all with p-values less than
0.0001). Together, these data indicate successful immunoprecip-
itation of SOX3-associated chromatin.
Alignment of the peak sequences to the genome revealed that
they were associated with 4636 unique nearest neighbouring genes
(approximately 20% of genes from the mm9 genome [24]). The
majority (60.5%) were located in intergenic regions, 28.5% were
located within introns and the remaining 11% were located near
the proximal promoter (Figure 1A). GO term analysis revealed
that peaks located in intergenic regions were most significantly
associated with genes involved in forebrain neuron development
(including Gli3, Pax6 and Wnt8b) and hindbrain development
(including Hoxa1, Smo and Wnt8a) (Figure 1D; Table S2). Peaks
located within intronic regions were highly associated with neural
tube development and formation (such as Shroom3, Wnt3 and
Zeb2). In contrast, peaks located at promoters were significantly
associated with genes involved in chromatin modification (includ-
ing a range of Histone 1, 2 and 4 variants and Rbbp4) (Figure 1D;
Table S2).
Conservation of SOX3 binding sites
To assess the evolutionary conservation of each peak, we
calculated the average phastCons score from data generated from
30 placental mammals provided from the UCSC database. Scores
range from 0 to 1 where a value greater than 0.1 shows some
conservation between placental mammals, while a value greater
than 0.5 is considered highly conserved [25]. The majority (more
than 56%) of peaks showed had an average score above 0.1, while
more than 20% of peaks exhibited a high level of conservation
with a value greater than 0.5 (Figure 2A). When peaks were sorted
by genomic location those located in intronic or intergenic regions
showed similar levels of conservation (more than 50% above 0.1),
while more than 70% of peak located at promoters scored above
0.1. All three locations had a similar percentage of highly
conserved peaks scoring more than 0.5 (approximately 20% each).
For example, the SOX3 peak within intron 2 of Dbx1, a known
target of SOX3 [21] has a conservation score of 0.97 and is
located within a region of high conservation (Figure 2B). The
SOX3 peak within intron 2 of Nestin, a well-characterised
enhancer shown to bind SOXB1 proteins [26], has an average
phastCons score of 0.51 where half the peak is highly conserved
while the remaining half is not (Figure 2C).
Identification of putative neural enhancers that bind
SOX3
To identify possible enhancers bound by SOX3 in NP cells, we
overlayed our ChIP-Seq dataset with ChIP-Seq data for the
coactivator protein P300 generated from 11.5 dpc embryonic
mouse forebrain and midbrain [27]. Peaks were classified as
overlapping if the midpoints of each peak were within 300 bp.
This comparison revealed that SOX3 bound to approximately
20% and 29% of P300 enhancer regions in the forebrain and
midbrain, respectively (Figure 3A, B). Although relatively small,
the overlap between these datasets is highly significant, with p-
values less than 1025. In contrast, comparison of SOX3 ChIP-seq
data with P300 sites from the 11.5 dpc mouse limb bud revealed
less that 5% overlap (a non-significant overlap, P,0.6) (Fig-
ure 3C). Interestingly, greater than 85% of the common peaks in
fore- and midbrain samples had conservation scores above 0.1
while 32% and 41% of fore- and midbrain samples, respectively,
were highly conserved (.0.50; Figure 3D, E).
Identification of conserved SOXB1 binding sites
Given the overlapping expression and functional redundancy of
Sox1, Sox2 and Sox3, we next attempted to identify common
binding sites for SOXB1 proteins in the developing CNS.
Comparison of our SOX3 ChIP-Seq dataset to existing ChIP-
Seq data for SOX2 and SOX3 generated from a similar NP cell
type [2] revealed 648 binding sites that were common to all three
datasets (Figure 4A). Strikingly, MEME-ChIP analysis identified
two variants of the SOX consensus motif, one of which is common
to all 648 peaks (Figure 4B i), and the second present within 285
peaks (Figure 4B ii). 50% of these peaks showed high conservation,
with phastCons scores greater than 0.5, while more than 80%
have a score of more than 0.1 (Figure 4C).
Only 2.5% of the SOXB1 binding sites were located in
promoter regions, whereas 34% were located within introns and
the remaining 63.5% were located within intergenic regions
(Figure 4D). GO term enrichment for the 648 SOXB1 peaks
indicated that transcription factors were the most common genes
regulated by these binding sites (Figure 4E). Intronic sites tend to
regulate genes involved in neurogenesis (such as Fezf2, Robo1, and
Slit1) while intergenic sites bind near transcription factors (such as
SOX3 Enhancers in Neural Progenitor Cells
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Irx, Nkx, and SOX family members; Figure 4F). Together, these
data define a core set of SOXB1 target sites that appear to have
evolutionally conserved roles in NP cells.
Identification of SOX3 binding sites in SOX3 target genes
Although SOXB1 proteins have highly overlapping functions,
comparison of genome-wide expression profiles of WT and Sox3
null NP cells has identified a set of 19 genes with significantly
different expression levels, suggesting that a small subset of
SOXB1 targets are particularly sensitive to the loss of SOX3 [21].
To investigate whether these genes are direct SOX3 targets, we
examined our ChIP-Seq data for binding sites with their intronic
and flanking sequences. Thirteen of the 19 differentially expressed
genes (68%, with an expected random frequency of 24%, and a p
value of less than 0.0001) featured at least one ChIP peak
(Table 1), two of which were located at promoters, nine within
introns and the remaining seven within intergenic regions.
Together, these data suggest that small subset of SOX3 direct
target genes require SOX3 (and not other SOXB1 members) for
normal expression.
SOX3 interaction with an interchromosomal
transcriptional network
A recent study has published a dataset for chromatin interaction
analysis with paired end tagging (ChIA-Pet) of RNA polymerase II
in neural stem cells [17]. They identified more than 5,000 putative
enhancers linked to the promoter of genes on different chromo-
somes (interchromosomal interactions), as well as more than
10,000 enhancers linked to distant genes on the same chromo-
some. We sought to identify whether SOX3 could be linked to any
of these putative inter- or intra- chromosomal enhancers identified
from a neural stem cell population. From the 8067 SOX3 peaks
identified, 97 overlapped with potential long-range enhancers (a
significant overlap, P,0.001, with an expected overlap of 34 by
chance) that can be linked to 304 and 246 inter- and
intrachromosomal promoters, respectively. For example, SOX3
binds an intronic enhancer within Tex14 (Figure 5) that can be
linked to 263 different promoters and enhancers. This putative
enhancer has a phastCons score of 0.12, moderate evolutionary
conservation, and features a single SOX binding site. These data
suggest that SOX3 may be involved in complex, long-range gene
regulation.
Discussion
This study has identified 8067 regions within the genome of
murine NP cells that are associated with SOX3. The majority of
the SOX3 binding sites are not located at the proximal promoter
of genes but rather are within intronic or intergenic regions,
suggesting an extensive regulatory (enhancer-binding) role for
SOX3 in NP cells. Interestingly, the most common motif within
Figure 1. Overview of SOX3 ChIP-Seq data from mouse neural progenitor cells. (A) Genomic classification of SOX3 binding sites relative to
nearest transcriptional start sites. (B) Validation of SOX3 ChIP by qPCR. Fold change is relative to both input DNA and IgG control values for the same
genomic location. Error bars correspond to standard deviation of three independent sample replicates, P-values indicated as,0.05 (ns),.0.05 (*) and
.0.001 (**). (C) Highest enriched DNA motifs identified by MEME-ChIP as i. a SOX motif and ii. a SOX-POU motif. (D) Enriched Gene Ontology terms
associated with subsets of SOX3 ChIP peaks.
doi:10.1371/journal.pone.0113361.g001
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these peaks was a variation of the standard SOX DNA binding
motif that contained a strong preference for a C residue at position
10 (C10) instead of a T (T10). Significant enrichment for C10 was
also identified by Bergsland et al. 2011 using an independent
SOX3 antibody, although not to the same degree as in our study.
Previous structural studies of SOX2 binding to a T10-containing
binding site indicate that T10 makes contact with arginine 5 of the
HMG domain as well as the c-terminal tail. However, as residues
within these regions are completely conserved throughout SOXB1
members, it remains unclear why SOX3 prefers to bind the C10
sequence in vivo. Given that partner factors can influence SOXB1
binding site preference [28], it is possible that the strong
enrichment for the C10 site may reflect SOX3 partner protein
usage in NPCs.
SOX3-POU cooperation
SOX transcription factors cooperate extensively with specific
partner factors, including OCT, BRN, or other SOX family
Figure 2. Evolutionary conservation of SOX3 bound regions. (A) The average phastCons score of each SOX3 bound peak showing 20% of
peaks are highly conserved across 30 placental mammals. (B) A highly conserved peak within the second intron of Dbx1 giving the highest
conservation score of 0.97 (compared to all peaks). (C) A peak within the second intron of the neural gene Nestin, with an average phastCons score of
0.51.
doi:10.1371/journal.pone.0113361.g002
Figure 3. SOX3 binding sites at enhancer regions. The overlap of SOX3 peaks with P300 binding sites identified from 11.5 dpc mouse;
forebrain (A), midbrain (B), and limb (C), showing a high degree of overlap in the developing brain and not within the limb. Average phastCons score
of the common peaks between SOX3 and P300 forebrain (D) and midbrain (E) binding sites.
doi:10.1371/journal.pone.0113361.g003
SOX3 Enhancers in Neural Progenitor Cells
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members [29]. Co-factor DNA binding is a common develop-
mental mechanism that provides exquisite temporal and spatial
expression of target genes [30]. The second most common motif
identified from the complete SOX3 ChIP-Seq dataset (within
1998/8067 peaks) was a combined SOX/POU DNA binding
motif (Figure 1). Similar enrichment of this motif was also
identified in the SOXB1 subset (126/648 peaks; p value ,
0.0001) [31]. The nucleotides comprising the POU component of
the SOX/POU motif show minimal variation, while the
nucleotides comprising the SOX motif show greater variability,
suggesting the POU-DNA interaction is more sensitive to
sequence composition. To assign functional significance to these
binding sites it would be useful to delete these binding sites either
completely or each of the SOX and POU binding sites separately
[32]. This could provide information as to the importance of these
linked binding sites indicating whether both factors required or if
one is sufficient.
Many SOX3 binding sites exist within biologically
important enhancers
Although the preferential binding of SOX3 in or near many
known neurodevelopmental genes is suggestive of a wide-ranging
regulatory role in NP cells, it is difficult to identify the functional
significance of these sites from binding data alone. To address this,
we assessed the evolutionary conservation of each ChIP peak, with
the rationale that a highly conserved peak has the potential to be
more biologically relevant if selection pressure has maintained
sequence conservation throughout evolution. The proposed link
between conservation and function is supported by previous
studies that have demonstrated that developmental enhancers can
be reliably identified solely on sequence conservation [33,34]. Our
data show over 50% of SOX3 peaks are either moderately (36%)
or highly (20%) conserved, having PhastCons scores above 0.1 or
0.5, respectively. Amongst the highly conserved peaks we
identified the well-characterised intronic Nestin enhancer that
has been shown previously to bind SOXB1 proteins in vitro and
drives NP cell expression of reporter genes in the developing CNS
[26]. We also identified a SOX3 peak within the second intron of
Dbx1 that had the highest overall conservation score and has been
linked to the expression of Dbx1 in cultured NPCs and the spinal
cord of 9.5 dpc Sox3 null mice [21]. In addition, SOX3 peaks
were identified at independently identified cis regulatory motifs
(CRM) shown to respond to SOXB1 transcription factors
including Olig2, Dbx2 and Nkx2.2, although not at the remaining
CRMs identified in this study [35]. Further comparison of our
data to ChIP-Seq data for the co-activator P300 from mouse
11.5 dpc forebrain and midbrain, identified 457 (19.85%) and 162
(28.88%) common peaks, respectively. Many of these P300
Figure 4. Identification of common SOXB1 regulatory regions. (A) Overlap of this SOX3 ChIP-seq dataset with previously published SOX2 and
SOX3 datasets from similar NPCs (2). (B) SOX motif identified with MEME-ChIP present in (i) all 648 SOXB1 common peaks and (ii) 295 peaks. (C)
Average phastCons scores for the 648 SOXB1 peaks, showing more than 80% of peaks are either moderately (32%) or highly (42%) conserved. (D)
Genomic localisation of the common SOXB1 peaks. Enriched Gene Ontology terms for (E) all 648 SOXB1 peaks and (F) both intronic and intergenic
peaks.
doi:10.1371/journal.pone.0113361.g004
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associated regions have been shown to function as CNS enhancers
in vivo [27]. Interestingly, overlapping SOX3/P300 peaks showed
an increased enrichment for high conservation with .32%
(forebrain) and .41% (midbrain) of peaks being highly conserved.
Overlapping P300 peaks from the limb also showed high
conservation, approximately 42%, which is to be expected given
P300’s high level of association with enhancers. Although only a
small percentage of the total number of SOX3 ChIP peaks, this is
only data pertaining to one co-activator (P300), it is likely that
other peaks feature alternate co-activators or other proteins
required for SOX3 to act as a pioneering factor [2]. Taken
together, these data suggest that many SOX3 peaks are likely to
correspond to important NP enhancers.
Previous ChIP-Seq analysis of SOX3 in a similar population of
NP cells also identified extensive binding across the genome (9719
SOX3 binding sites). Comparison to our dataset identifies more
than 15,000 unique SOX3 binding sites, 2625 of which are
common to both studies. Although both analyses produced a
similar number of binding sites individually, the overlap in binding
sites between datasets was lower than anticipated. This variability
is likely to be caused by use of different NPCs. Although both
studies used NPCs that were generated from ES cells by N2B27
induction [20], the Bergsland et al. culture conditions also
included bFGF, SHH, and retinoic acid [2]. These additional
factors have major roles in CNS patterning and are therefore likely
to influence the identity of the overall NP cell population. It has
been observed previously the degree of overlap of binding sites
between different cell lines can vary, from less than 50% (SRF
peaks from 3 different human cell lines [36]) to more than 80%
overlap (E2F4 peaks from multiple primary mouse tissues and cell
lines [37]). It is also important to note that different SOX3
antibodies were used in the ChIP-seq studies. Although both have
been shown to be specific they likely recognise different SOX3
epitopes, potentially introducing variation in the SOX3 binding
sites identified.
Given the functional redundancy of SOXB1 proteins, we sought
to identify genomic regions bound by SOX3 and SOX2 in NP
cells. The 648 common SOXB1 binding sites showed greater
enrichment for conserved peaks than any of the datasets alone
with approximately 50% having high conservation. Remarkably,
two variants of the SOX motif were identified through de novo
screening of the 648 SOXB1 peaks. The most common motif was
found in all 648 peaks with a highly significant E value (4.7e-371).
This motif is very similar to the one identified from the complete
SOX3 dataset (although there was no nucleotide preference
observed at position 10), and essentially identical across positions
6, 7 and 9 which are known to make contact with the HMG
domain [4]. The second SOX motif identified was present in 285
peaks (with an E value of 1.5e-23) and was more similar to the
SOX3 motif, with an increased nucleotide preference at position
10. GO term analysis indicated that SOXB1 common peaks bind
nearest to transcription factors, in particular members of the SOX
family (including Sox1, Sox2, Sox4, Sox5, Sox6, Sox9, Sox11),
Nkx2.1 and Nkx2.2 all with known roles in neural development.
The intronic peaks are enriched for genes involved in neural
development, including Fzd3 and Fzd6 both of which are required
for correct ventricle formation in the developing midbrain [38].
Together these data give evidence that SOXB1 binding sites have
been highly conserved throughout evolution and potentially
regulate genes important for neural development, and also
suggests extensive cross regulation of SOX factors consistent with
analyses of individual factors [39,40].
The expression level of most NP genes is not affected by the loss
of Sox3 [21], presumably due to functional redundancy with other
SOXB1 members. However, we have previously identified
nineteen genes that have altered expression in Sox3 null NP cells,
suggesting that some genes are particularly sensitive to SOX3 loss
Table 1. Differentially expressed genes from Sox3 null NPCs with nearby SOX3 ChIP binding sites.
Gene Fold Change RefSeq ID Peak Coordinates Location
Tmem163 21.45 NM_028135 chr1:129472320-129472556 Intron
Slc44a5 1.44 NM_001081263 chr3:153836591-153836875 Intron
Fgfr3 1.65 NM_008010 chr5:34047895-34048514 Intergenic
Cpv1 1.41 NM_025817 chr6:53860009-53860356 Intron
chr6:53984529-53984835 Intergenic
Dbx1 22.35 NM_001005232 chr7:56889725-56889913 Intron
Gpr56 1.56 NM_018882 chr8:97524576-97524923 Intron
Cspg5 1.49 NM_013884 chr9:110154883-110154975 Intron
chr9:110183673-110183904 Intergenic
Ctgf 1.45 NM_010217 chr10:24310458-24310740 Promoter
Flrt2 1.46 NM_201518 chr12:95662522-95662885 Intergenic
Ednrb 1.53 NM_007904 chr14:104243418-104243673 Promoter
chr14:104298351-104298531 Intergenic
chr14:104298536-104298789 Intergenic
Tagln3 1.54 NM_019754 chr16:45724870-45725203 Promoter
Slit1 1.87 NM_015748 chr19:41745438-41745636 Intron
chr19:41773461-41773782 Intron
chr19:41790683-41791049 Intron
Sox3 24.10 NM_009237 chrX:57972960-57973254 Intergenic
doi:10.1371/journal.pone.0113361.t001
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of function. Here we show that the majority of these genes (68%)
are directly bound by SOX3. The high frequency of binding sites
in differentially expressed genes appears significant given that
SOX3 binding sites on average are found in only 20% of genes
genome wide. The mechanism that underpins the sensitivity of
these direct targets to the loss of SOX3 alone is currently unclear.
Given that the HMG box sequences of the SOXB1 proteins are
not identical, one possibility is that the binding sites in these
differentially expressed genes have a higher affinity for SOX3 than
other SOXB1 proteins. Alternatively, these genes may be sensitive
to the overall dosage of SOXB1 protein rather than SOXB1 itself.
Additional studies such as SoxB1 gene swap experiments are
required to further investigate this issue.
Finally we have identified a number of potential genome wide
interactions, linking enhancers and promoters of genes regulated
by SOX3. It was observed that an intronic enhancer within Tex14
could be linked to many other enhancers and promoters, forming
a transcriptional hub. These networks may aid in ensuring
transcription of specific genes occurs at similar time, potentially
allowing for quicker responses. As noted by Zhang et al. 2013 the
RNAPII data identifies regions of pre-initiation events; as such not
all genes will be actively transcribed. Further to this, it is likely that
there are other long-range interactions that do not involve
RNAPII. It could be informative to perform a ChIA-PET against
SOX3 in NPCs to see what long-range interactions occur
independent of RNAPII. It would also be interesting to see
whether deleting one of the binding sites that form part of a
transcriptional hub, such as Tex14, has an effect on the
transcription at connected genomic locations.
Conclusions
In conclusion, we have shown that SOX3 binds extensively to
evolutionarily conserved sequence in or near known neurodevel-
opmental genes that are likely to function as enhancers. Further
functional validation within an in vivo system is required to assess
the functional importance of these data. With the recent
emergence of genome editing tools, CRISPR and TALENs, the
generation of genetically modified mice has become significantly
more streamlined and efficient. This technology will allow for the
simple deletion or modification of binding sites in mice to highlight




Mouse R1 ES cells, as described previously [10,22], were
passaged without feeders in DMEM (Gibco) in the presence of LIF
Figure 5. SOX3 is implicated in an interchromosomal regulatory network. Graphical representation of potential long range intra- and
interchromosomal interactions as identified by overlap of SOX3 peaks with RNAPII ChIA-PET peaks. Blue circles are sites present in both SOX3 and
RNAPII datasets, while green circles are the linked genomic regions present only in the RNAPII dataset. The nearest TSS is labelled for the common
binding sites.
doi:10.1371/journal.pone.0113361.g005
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and foetal calf serum. ES cell monolayers were cultured in N2B27
media for 4 days to produce NPCs as described previously [20].
SOX3 ChIP-seq
NPCs were fixed in 1% formaldehyde for 8 minutes at room
temperature, lysed and sonicated (Bioruptor, Diagenode) for
15 minutes in 1-minute pulses on ice. SOX3 bound chromatin
was immunoprecipitated by a goat polyclonal antibody raised
against human SOX3 (R&D systems, AF2569). DNA was
recovered by reversing crosslinks, and purified by PCR clean-up
kit (QIAGEN). Three independent DNA libraries were produced
with the Illumina TrueSeq library kit as per manufacturer’s
instructions, and libraries were sequenced on the Illumina HiSeq
producing 50 bp single end reads. A control sample (without
SOX3 antibody) was run as input for background control. ChIP
samples were validated by qPCR (StepOne Plus, Applied
Biosystems) using Fast SYBR (Life Technologies). Signals were
considered positive when Ctsample (non-enriched region) - Ctsample
(peak region) was .2 following normalisation to CtIgG.
Peak Calling
Bowtie [41] was used to align reads to the mouse genome
(mm9). Peaks were called for each biological replicate using
MACS [42], with bandwidth of 300, a model fold of 10–30, using
input sample as background control, and a p-value threshold of 1e-
5. Only peaks present in all 3 biological replicates were retained.
Gene ontology
Gene ontology was performed using GREAT (http://great.
stanford.edu/) for regions associated with SOX3 bound enhancers
[43]. Default ‘basal plus’ parameters were used to define gene
locus, and the whole genome was used for background regions.
De Novo motif enrichment
MEME (http://meme.sdsc.edu/) was used to identify DNA
enriched motifs from SOX3 bound peaks [44]. WebLogo [45] was
used to visualise de novo motifs generated by MEME-ChIP.
Published ChIP-Seq data
ChIP-Seq data on SOX2 and SOX3 in NPCs were obtained
from GSE33024, P300 data from GSE10516, ChIA-PET data
from GSE44067.
Primers for qPCR
Primers for validating ChIP samples by qPCR are listed in a 59
to 39 direction as follows: Nes F- GCCCCAGTCAGTCTTCT-
GAG, R- GCTGGTGACAGACAAAAGCA,
Cp F- CTCACACTGTGCTGGGCTAA, R- AGGAAGT-
fTGTGCAACTCTGGA,
Ednrd F- CTAAACAGGCCTCTCGCAAC, R- TTGTC-
TGGGGACAGCAAAG,
Enfb3 F- ATGCTCAGCACCTCATTGG, R- GGCACGT-
GACTGGTGGTAG,
Fezf2 F- GGTCGTCTTTTCTTCCTGTCC, R- ATCCA-
CAGAACCAGCATCACT,
Slc44a5 F- CTGCCTGGATGTCAGGATTT, R- CCCA-
CAGTGTTTGTAGGAACG,
Sox3 F- ATGAGTTTCCGGAATGTTGC, R- CTTCTCA-
CTTCCTGCCCTTG,
Tagln3 F- CCTCTCCTAGACAGGCCAGA, R- GTGG-
GGCCTCAGATACAATG,
Slit1 F- AGACGGACCTGGGAAATTCT, R- CCAGAAAG-
CAGGATTTGCAT
Supporting Information
Table S1 A list of all SOX3 peaks identified by ChIP-
seq. Featuring mm9 coordinates, nearest gene, RefSeq gene ID
and distance from centre of peak to nearest transcriptional start
site.
(XLSX)
Table S2 A list of the top 20 GO terms associated with
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